CRISM Therapeutics Corporation Cash Flow-to-Debt Ratio
CRISM Therapeutics Corporation cash flow-to-debt ratio. CRISM Therapeutics Corporation (CRTX) has a Cash Flow-to-Debt Ratio of -4.32x as of June 2026, meaning its operating cash flow of GBX-1.48 Million could theoretically repay -4% of its total liabilities (GBX343.00K) in one year. Check how high is CRISM Therapeutics Corporation's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CRISM Therapeutics Corporation (2006–2025)
Cash flow-to-debt ratio of CRISM Therapeutics Corporation from 2006 to 2025. Historical debt coverage capacity for CRISM Therapeutics Corporation across 20 annual periods. Also explore net asset momentum of CRISM Therapeutics Corporation to track the company's year-over-year net asset growth rate.
CRISM Therapeutics Corporation Cash Flow-to-Debt Ratio by Year (2006–2025)
CRISM Therapeutics Corporation cash flow-to-debt ratio by year from 2006 to 2025. Year-by-year debt coverage analysis for CRISM Therapeutics Corporation. For the full cash flow conversion analysis, see how efficiently does CRISM Therapeutics Corporation generate cash.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.16x | GBX-1.97 Million | GBX381.00K | ▼ -88.7% |
| 2024 | -2.74x | GBX-933.00K | GBX341.00K | ▲ +9.1% |
| 2023 | -3.01x | GBX-2.77 Million | GBX920.19K | ▲ +34.4% |
| 2022 | -4.59x | GBX-3.52 Million | GBX765.65K | ▼ -182.3% |
| 2021 | -1.63x | GBX-1.83 Million | GBX1.13 Million | ▲ +24.9% |
| 2020 | -2.17x | GBX-2.28 Million | GBX1.05 Million | ▲ +2.9% |
| 2019 | -2.23x | GBX-1.90 Million | GBX852.24K | ▼ -151.2% |
| 2018 | -0.89x | GBX-2.46 Million | GBX2.76 Million | ▲ +69.0% |
| 2017 | -2.86x | GBX-2.70 Million | GBX944.00K | ▼ -453.2% |
| 2016 | -0.52x | GBX-2.01 Million | GBX3.88 Million | ▲ +87.7% |
| 2015 | -4.22x | GBX-2.99 Million | GBX709.20K | ▲ +12.4% |
| 2014 | -4.81x | GBX-1.96 Million | GBX407.00K | ▲ +77.9% |
| 2013 | -21.79x | GBX-1.62 Million | GBX74.25K | ▼ -112.4% |
| 2012 | -10.26x | GBX-750.98K | GBX73.21K | ▲ +60.8% |
| 2011 | -26.17x | GBX-2.67 Million | GBX102.00K | ▼ -268.6% |
| 2010 | -7.10x | GBX-778.08K | GBX109.60K | ▼ -143.5% |
| 2009 | -2.92x | GBX-843.95K | GBX289.43K | ▲ +58.7% |
| 2008 | -7.06x | GBX-2.06 Million | GBX292.12K | ▼ -78.6% |
| 2007 | -3.95x | GBX-692.47K | GBX175.32K | ▲ +93.8% |
| 2006 | -63.55x | GBX-998.08K | GBX15.71K | — |